| Product NDC: | 16590-305 |
| Proprietary Name: | TRIFLUOPERAZINE |
| Non Proprietary Name: | TRIFLUOPERAZINE |
| Active Ingredient(s): | 2 mg/1 & nbsp; TRIFLUOPERAZINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-305 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA085786 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19811120 |
| Package NDC: | 16590-305-60 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (16590-305-60) |
| NDC Code | 16590-305-60 |
| Proprietary Name | TRIFLUOPERAZINE |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (16590-305-60) |
| Product NDC | 16590-305 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TRIFLUOPERAZINE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19811120 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | TRIFLUOPERAZINE HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |